Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
China
Enrollment target
~17 participants
Started
May 2022
Primary completion
September 2027
Age range
18 Years – 80 Years
Last updated on clinicaltrials.gov in April 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Jun Huang, MD
Sixth Affiliated Hospital, Sun Yat-sen University